Tenecteplase for treatment of acute myocardial infarction. - Wikidata - awgldk - TriplyDB

Tenecteplase for treatment of acute myocardial infarction.

Tenecteplase for treatment of acute myocardial infarction.

http://www.wikidata.org/entity/Q34417294

about

Advances in haematological pharmacotherapy in 21st century.

P2860

Q34406838-3F56D216-1C49-4ED1-BB1A-A592F099B617

P2860

Tenecteplase for treatment of acute myocardial infarction.

http://www.wikidata.org/entity/Q34417294

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Tenecteplase for treatment of acute myocardial infarction.

@ast

Tenecteplase for treatment of acute myocardial infarction.

@en

Tenecteplase for treatment of acute myocardial infarction.

@nl

type

label

Tenecteplase for treatment of acute myocardial infarction.

@ast

Tenecteplase for treatment of acute myocardial infarction.

@en

Tenecteplase for treatment of acute myocardial infarction.

@nl

prefLabel

Tenecteplase for treatment of acute myocardial infarction.

@ast

Tenecteplase for treatment of acute myocardial infarction.

@en

Tenecteplase for treatment of acute myocardial infarction.

@nl

P1433

Q34417294-0D81BD56-EA0B-41B4-81D5-5FF1A48AB442

P1476

Q34417294-FC1BD982-A0B6-40FA-A18D-037ED088D1FB

P2093

Q34417294-0D7CE9E6-F16B-48FB-8892-A0F887FBE727

Q34417294-3EF56E1C-03FF-4452-855D-8FF59D51FF18

P2860

Q34417294-1CCF5353-92FA-45FC-9698-81BD2C403CE9

Q34417294-1EF80D6B-1593-4E66-9DC7-42B6D6A6E76C

Q34417294-25F99375-CCD0-4216-A12A-933511203E64

Q34417294-51D81A6A-92FB-47F4-9275-6F1DDD0ADA65

Q34417294-60755A80-3384-43F3-9D6E-42DF903FD786

Q34417294-770BA875-74A5-4A5F-9B1C-A7471B6D8446

Q34417294-C473D561-B767-45A7-B413-16A85774E5D8

Q34417294-D1781951-4DFD-4BC5-8CEB-1CF7723A46A6

Q34417294-E1D0ECC4-5158-43EB-9612-6B1291DCD47B

Q34417294-EA182536-E3DB-45D2-B5D8-336EB5AB7DD6

P304

Q34417294-25E8138E-8586-4B4E-B01D-0DCE7EE9CC54

P31

Q34417294-46D47CC5-BD68-4A19-A82F-171AE58EE242

P356

Q34417294-12AC8E90-3849-47DB-8D2C-1EAA1FBBA364

P407

Q34417294-9F175ACB-6866-46AD-AF5F-E37DEA02B821

P433

Q34417294-E47482CB-3213-4ED8-B283-3532C443592B

P478

Q34417294-B1DB6703-7EA1-446C-A880-7F00DA372A3D

P577

Q34417294-F1C9EA75-CB11-4ADA-82B1-4BCA6A2D5504

P5875

Q34417294-459CE6B4-163E-4D31-94CE-490069D07182

P698

Q34417294-3DD29A6A-9043-47AB-93F1-A6BBD3EDC1C1

P921

Q34417294-3C2B9490-4038-4B06-9506-F20EDBDBAE17

P356

P1433

Annals of Pharmacotherapy

P1476

Tenecteplase for treatment of acute myocardial infarction.

@en

P2093

J M Nappi

http://www.w3.org/2001/XMLSchema#string

N M Turcasso

http://www.w3.org/2001/XMLSchema#string

P2860

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Third-generation thrombolytic drugs.

Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.

Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

A comparison of reteplase with alteplase for acute myocardial infarction.

Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.

Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction.

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

P304

1233-1240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.10425

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11676656

http://www.w3.org/2001/XMLSchema#string

P698

11675853

http://www.w3.org/2001/XMLSchema#string

P921